Supreme Court Justice Ruth Bader Ginsburg, a diminutive yet towering women’s rights champion who became the court’s second female justice, died Friday at her home in Washington. She was 87.

Ginsburg died of complications from metastatic pancreatic cancer, the court said.

Ginsburg announced in July that she was undergoing chemotherapy treatment for lesions on her liver, the latest of her several battles with cancer.

Ginsburg spent her final years on the bench as the unquestioned leader of the court’s liberal wing and became something of a rock star to her admirers. Young women especially seemed to embrace the court’s Jewish grandmother, affectionately calling her the Notorious RBG, for her defense of the rights of women and minorities, and the strength and resilience she displayed in the face of personal loss and health crises.

Those health issues included five bouts with cancer beginning in 1999, falls that resulted in broken ribs, … Read more

In 2016, a Business Insider report on the use of emerging technologies in business showed that many business decision-makers would have chatbots in place by 2020.

800 business leaders responded to the survey – senior marketers, chief strategy officers, top sales executives, and chief marketing officers from Europe and Africa.

Some of the chatbot applications that these leaders were eyeing to implement included interactive software platforms common in email, apps, SMS, and live chat applications. 42{429fc2506e610357e12b2a5665db82631200a2e00b3a1d8839077d76f18e2e8b} of the respondents said that they would also activate chatbot technology in marketing, sales, and customer service.

Have the business executives actualized their intention to have chatbots in their business marketing strategies by 2020?

Today, 67{429fc2506e610357e12b2a5665db82631200a2e00b3a1d8839077d76f18e2e8b} of online visitors have had close interactions with a chatbot, and 58{429fc2506e610357e12b2a5665db82631200a2e00b3a1d8839077d76f18e2e8b} of businesses working with chatbots are B2B. These intelligent automated helpers handle an enormous chunk of the 2 billion messages that run between businesses and their Read more

The Manchester City and Nexen Tire partnership focuses on empowering young people through football and bold digital marketing campaigns

Manchester City team has announced it has renewed its strategic partnership with Korean tyre giant, Nexen Tire, taking the partnership into its third term through the new multi-year deal.

The partnership began in 2015 and has grown to include sponsorship of both the men’s and women’s teams, elite development squad and esports players as well as extensive collaborations across digital content campaigns and grassroots football programmes around the world.

The partnership made history in March 2017 when City became the first Premier League club to announce a sleeve partner, with Nexen Tire branding appearing on the playing shirts since the start of the 2017/18 season.

Starting from the upcoming 2020/21 season, Nexen’s sleeve sponsorship will extend to the City women’s team for all domestic competitions, the men’s team’s training kits … Read more

Snowflake (NYSE: SNOW) shares were listed on the New York Stock Exchange this week. On its first day of trading, the share price popped higher to more than double. The cloud data warehousing firm had the largest software initial public offering (IPO) on record, valuing it at around $70bn – more than five times the private market valuation it reached in February.

Snowflake shares were priced at $120, after being revised higher twice this month. On the first day of trading, the share price climbed to over $300, and finished the day up 112{429fc2506e610357e12b2a5665db82631200a2e00b3a1d8839077d76f18e2e8b} at $255.

Early investors of Snowflake shares include Salesforce and Berkshire Hathaway. The investment by the conglomerate run by Warren Buffett is interesting. Buffett rarely gets interested in technology startups that are not yet profitable, and tends to opt for more mature companies.

Snowflake’s IPO comes at a similar time to several technology IPOs. It … Read more

In the global sprint to find a COVID-19 vaccine, we’ve seen the world embrace approaches that would have previously been considered unthinkable, from spending billions on untested technologies to compressing clinical trials from years to months. 

These bold steps may be exactly what the world needs to find a vaccine even one day sooner. But unless we bring the same kind of urgency, inventiveness, and investment to vaccine distribution as we have to vaccine development, our attempts to end the COVID-19 pandemic will fail.

Why does delivering the one thing everyone in the world needs merit such an audacious approach? Because vaccines are delicate things; they require near-perfection in our ability to deliver them. 

The COVID-19 vaccine, like most vaccines, will need to be kept cold, fixed within a precise temperature range from the moment it leaves the manufacturer to the moment it’s administered. 

This is hard even in rich … Read more